Evidence map›Paper›PMID 41984502›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2026

Folate receptor beta drives NLRP3 inflammasome activation and pyroptosis in macrophages independent of folate binding.

Lisa M Rogers, Kyle Firestone, Riya Chinni, Anna C Branco, Kayla Wrobleski, Teresa Chou, Jeffery A Goldstein, Xiaoping Gu, Emily Mason, Shaoyou Chu and 3 more

Abstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Lisa M RogersDivision of Infectious Diseases, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, United States.
Kyle FirestoneDivision of Infectious Diseases, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, United States.
Riya ChinniDivision of Infectious Diseases, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, United States.
Anna C BrancoDivision of Infectious Diseases, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, United States.
Kayla WrobleskiDivision of Infectious Diseases, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, United States.
Teresa ChouDepartment of Pathology, Northwestern University School of Medicine, Chicago, IL, United States.
Jeffery A GoldsteinDepartment of Pathology, Northwestern University School of Medicine, Chicago, IL, United States.ORCID 0000-0002-4086-057X
Xiaoping GuDivision of Clinical Pharmacology, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, United States.
Emily MasonDivision of Clinical Pharmacology, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, United States.
Shaoyou ChuDivision of Clinical Pharmacology, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, United States.
Michael Rubart-von der LoheDepartment of Pediatrics, Indiana University School of Medicine, Indianapolis, IN, United States.
Philip LowDepartment of Chemistry and Institute for Drug Discovery, Purdue University, West Lafayette, IN, United States.
David M AronoffDivision of Infectious Diseases, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, United States.ORCID 0000-0003-4587-6121

Funding

Tumor Microenvironment and Metastasis ProgramP30CA082709 · NCI · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI David W Clapp · 1999 to 2026
$59.3M
Project-005U54DK106846 · NIDDK · INDIANA UNIVERSITY INDIANAPOLIS · PI Reuben Kapur, Karen Elizabeth Pollok · 2015 to 2026
$9.7M
BD FACSAria SystemS10OD012270 · OD · INDIANA UNIVERSITY INDIANAPOLIS · PI SROUR, EDWARD F · 2013 to 2013
$516k
NCI NIH HHS P30 CA082709NIDDK NIH HHS U54 DK106846NIH HHS S10 OD012270
6 · The paper itself

Abstract

Folate receptor beta (FRβ), encoded by FOLR2, is selectively expressed in monocytes and macrophages, yet its function in innate immune signaling remains poorly defined. Here, we identify FRβ as a novel regulator of NLRP3 inflammasome activation and pyroptosis in human THP-1 macrophages. Using CRISPR/Cas9-mediated gene deletion, we show that loss of FOLR2 severely impaired caspase-1 activation, gasdermin D cleavage, and IL-1β release in response to multiple NLRP3 stimuli, without altering pro-IL-1β induction. These defects were not rescued by exogenous folate and were independent of extracellular folate concentrations. Mechanistically, FOLR2/FRβ appears to potentiate potassium efflux and the expression of multiple potassium channel-encoding genes. Single-cell RNA sequencing revealed broad transcriptional repression in FRβ-deficient macrophages, including genes involved in inflammasome signaling and ion transport. Genome-wide methylation profiling showed increased CpG hypermethylation in FOLR2-deficient cells, consistent with reduced transcriptional activity. Our findings indicate that FRβ promotes NLRP3 activation in a folate-independent manner potentially by regulating DNA methylation, gene transcription, and K+ efflux in macrophages. These findings uncover a previously unrecognized immunoregulatory function for FRβ, positioning it as a potential modulator of macrophage-driven inflammation in contexts such as host defense, autoimmunity, and tissue-specific immune responses at the tumor and maternal-fetal interface.

Indexed as

Folate Receptor 2Folic AcidInflammasomesMacrophagesNLR Family, Pyrin Domain-Containing 3 ProteinPyroptosisDNA MethylationHumansPotassiumSignal TransductionTHP-1 CellsFolate Receptor 2Folic AcidFOLR2 protein, humanInflammasomesNLR Family, Pyrin Domain-Containing 3 ProteinNLRP3 protein, humanPotassiumDNA methylationfolate receptor betaFRβmacrophage activationNLRP3 inflammasome

Identifiers

PMID41984502
PMCPMC13351659

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.